MMP9 and gastric carcinoma: Further research yielded the development of drugs specifically against MMP9, and the effect of humanized monoclonal antibodies (ANDECALIXIMAB) against the enzyme has been studied in gastric carcinoma, which showed moderate efficacy when they were given in combination with other cytotoxic drugs [22].